Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples

Journal of Clinical Virology

Volumn 58, Issue 3, 2013, Pages 535-540

  Ottiger, Cornelia ^a   Gygli, Nicole ^a   Huber, Andreas R ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Anti HCV; Architect; HCV core antigen; HCV genotype; HCV PCR; HCV RNA; HCV viral load; Hepatitis C

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ALGORITHM; ANALYTICAL EQUIPMENT; ANTIBODY SCREENING; ANTIGEN DETECTION; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LOAD;

ANTI-HCV; ARCHITECT; COEFFICIENT OF VARIATION; CV%; EDTA; ETHYLENE DIAMINETETRAACETIC ACID; HCV AG; HCV CORE ANTIGEN; HCV GENOTYPE; HCV PCR; HCV RNA; HCV VIRAL LOAD; HEPATITIS C; HEPATITIS C VIRUS CORE ANTIGEN; HEPATITIS C VIRUS RIBONUCLEIC ACID;

ALGORITHMS; ANTIGENS, VIRAL; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIMIT OF DETECTION; RNA, VIRAL; VIRAL LOAD;

EID: 84886312017     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.028     Document Type: Article

References (22)

1. Barrera J.M., Francis B., Ercilla G., Nelles M., Achord D., Darner J., et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995, 68:15-18.
2. Hoofnagle J.H. Hepatitis C: The clinical spectrum of disease. Hepatology 1997, 26(3 Suppl 1):15S-20S.
3. Pawlotsky J.-M., Lonjon I., Hezode C., Raynard B., Darthuy F., Remire J., et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?. Hepatology 1998, 27:1700-1702.
4. Piro L., Solinas S., Lucani M., Casale A., Bighiani T., Santonocito D., et al. Prospective study of the meaning of indeterminate results of the Recombinant Immunoblot Assay for hepatitis C virus in blood donors. Blood Transfus 2008, 6:107-111.
5. Asselah T., Estrabaud E., Bieche I., Lapalus M., De Muynck S., Vidaud M., et al. viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver Int 2010, 30:1259-1269.
6. Kamili S., Drobeniuc J., Araujo A.C., Hayden T.M. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 2012, 55(suppl.). S43-S48.
7. Bibert S., Roger T., Calandra T., Bochud M., Cerny A., Semmo N., et al. The Swiss hepatitis C cohort study. IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J Exp Med 2013, 210:1109-1116.
8. Schreier E., Roggendorf M., Driesel G., Höhne M., Viazov S. Genotypes of hepatitis C virus isolates from different parts of the world. Arch Virol 1996, Suppl.11:185-193.
9. Kanai K., Kako M., Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992, 339(8808):1543.
10. Santolini E., Migliaccio G., La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994, 68:3631-3641.
11. Ansaldi F., Buzzone B., Testino G., Bassetti M., Gasparini R., Crovari P., et al. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. J Viral Hepat 2006, 13:5-10.
12. Muerhoff A.S., Jiang L., Shah D.O., Gutierrez R.A., Patel J., Garolis C., et al. Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay. Transfusion 2002, 42:349-356.
13. Kim S., Kim J.-H., Yoon S., Park Y.-H., Kim H.-S. Clinical performance evaluation of four automated Chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol 2008, 46:3919-3923.
14. Cano H., Candela M.J., Lozano M.L., Vicente V. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors. Transfus Med 2003, 13:259-266.
15. Kesli R., Polat H., Terzi Y., Kurtoglu M.G., Uyar Y. Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) Core antigen test with the hcv rna assay for clinical usefulness in confirming anti-HCV results. J Clin Microbiol 2011, 49:4089-4093.
16. Pas S., Molenkamp R., Schinkel J., Rebers S., Copra C., Seven-Deniz S., et al. Performance evaluation of the New Roche cobas AmpliPrep/cobas TaqMan HCV Test, Version 2.0, for detection and quantification of hepatitis C Virus RNA. J Clin Microbiol 2013, 51:238-242.
17. Aoyagi K., Ohue C., Iida K., Kimura T., Tanaka E., Kiyosawa K., et al. Development of a simple and highly sensitive enzyme immunoassay for Hepatitis C virus core antigen. J Clin Microbiol 1999, 37:1802-1808.
18. Laperche S., Le Marrec N., Girault A., Bouchardeau F., Servant-Delmas A., Maniez-Montreuil M., et al. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 2005, 43:3877-3883.
19. Park Y., Lee J.-H., Kim B.S., Kim D.J., Han K.-H., Kim H.-S. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol 2010, 48:2253-2256.
20. Hosseini-Moghaddam S.M., Iran-Pour E., Rotstein C., Husain S., Lilly L., Renner E., et al. core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?. Rev Med Virol 2012, 22:156-165.
21. Robert, Koch-Institut Virushepatitis B. C und D im Jahr 2011. Epidemiol Bull 2012, 38.
22. Getchell J.P., Wroblewski K.E., DeMaria A., Bean C.L., Parker M.M., Teo C.-G., et al. Testing for HCV infection: an update of guidance for clinicians and laboratories. MMWR 2013, 62(18):362-365.